Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In relapsed or refractory diffuse large B-cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirine.
Caimi PF, Hamadani M, Carlo-Stella C, Nickaeen M, Jordie E, Utsey K, Knab T, Zammarchi F, Cucchi D, Pantano S, Havenith K, Wang Y, Boni J. Caimi PF, et al. Among authors: knab t. EJHaem. 2023 Nov 30;5(1):76-83. doi: 10.1002/jha2.816. eCollection 2024 Feb. EJHaem. 2023. PMID: 38406517 Free PMC article.
Bayesian PBPK modeling using R/Stan/Torsten and Julia/SciML/Turing.Jl.
Elmokadem A, Zhang Y, Knab T, Jordie E, Gillespie WR. Elmokadem A, et al. Among authors: knab t. CPT Pharmacometrics Syst Pharmacol. 2023 Mar;12(3):300-310. doi: 10.1002/psp4.12926. Epub 2023 Feb 5. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 36661183 Free PMC article.
Landscape analysis for a neonatal disease progression model of bronchopulmonary dysplasia: Leveraging clinical trial experience and real-world data.
Barrett JS, Cala Pane M, Knab T, Roddy W, Beusmans J, Jordie E, Singh K, Davis JM, Romero K, Padula M, Thebaud B, Turner M. Barrett JS, et al. Among authors: knab t. Front Pharmacol. 2022 Oct 12;13:988974. doi: 10.3389/fphar.2022.988974. eCollection 2022. Front Pharmacol. 2022. PMID: 36313352 Free PMC article.
Dosing regimen optimisation for oseltamivir in immunocompromised paediatric patients with influenza: Extrapolation of efficacy.
Jordie EB, Gibiansky L, Knab T, Lemenuel-Diot A, Ravva P, Zwanziger E, Jolivet S, Bhardwaj R, Hernández-Sánchez J, Nasmyth-Miller C, Sturm S. Jordie EB, et al. Among authors: knab t. Br J Clin Pharmacol. 2022 Mar;88(3):1189-1201. doi: 10.1111/bcp.15059. Epub 2021 Oct 15. Br J Clin Pharmacol. 2022. PMID: 34449090 Free article.